Autoimmune thyroid disorder in patient with chronic hepatitis C before treatment

Author(s):
Mehr Ali RahimiMehr Ali Rahimi1, Babak SayadBabak Sayad2, Ahmad Tahamoli RoudsariAhmad Tahamoli Roudsari3,*, Karoun ShahebrahimiKaroun Shahebrahimi1, Maria ShirvaniMaria Shirvani4, Mansour RezaeiMansour Rezaei5
1Dept of Internal Medicine, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
2Dept. of Infectious Medicine, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
3Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran
4Hepatitis Research Center, Emam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
5Dept. of Biostatistics and Epidemiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
*Corresponding Author: Corresponding author: Ahmad Tahamoli Roudsari, Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran, Tel: +98 831 4276300 Email: [email protected]

Journal of Kermanshah University of Medical Sciences:Vol. 15, issue 3; e79361
Published online:Sep 19, 2011
Article type:Research Article
Received:May 15, 2010
Accepted:Oct 05, 2010
How to Cite:Rahimi MA, Sayad B, Tahamoli Roudsari A, Shahebrahimi K, Shirvani M, et al. Autoimmune thyroid disorder in patient with chronic hepatitis C before treatment. J Kermanshah Univ Med Sci. 2011;15(3):e79361. doi:

Abstract

Background: Creating autoantibodies against thyroid in hepatitis C patients who are being treated with interferon is now recognized for several years. Recently, some studies have claimed that prevalence of autoimmune thyroid disorders in Hepatitis C patients is higher when they are not treated by interferon and/or at the beginning of diagnosis, however the area still remained controversial. In order to analyze autoimmune thyroid disorders in Hepatitis C patients who are not still treated by interferon and compare them with the control group this study has been conducted.

Methods: A Case-Control study including 86 chronic hepatitis C patients before commencing treatment by interferon and 86 healthy volunteer individuals were examined. Data was collected using demographic and clinical variables questionnaires from both groups. FT4, TSH, Anti TPO and Anti TG examinations carried out in both group.

Results: The findings of this study showed increase Anti TPO in 4 cases in 13 case, increased is Anti TG in 5 case, sub clinical hypothyroid, ism sub clinical hyperthyroid in 3 ism and hyperthyroid ism in one case in the case group were observed.  There was no significant difference between the case and the control group.

Conclusion: We can conclude that there is no relationship between chronic hepatitis C infection and autoimmune thyroid.

Fulltext

References

  • 1.
    The references of this article is available on PDF.

Copyright

© 2011, Journal of Kermanshah University of Medical Sciences. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

30
Jun
2009

Thyroid Dysfunction in Patients with Chronic Viral Hepatitis B and C during Alpha Interferon Therapy

Amir Ziaee,
Fatemeh Esfehanian,
Majid Sarreshtedari

Ziaee A, Esfehanian F, Sarreshtedari M. Thyroid Dysfunction in Patients with Chronic Viral Hepatitis B and C during Alpha Interferon Therapy. Hepat Mon. 2009;9(2):. doi:

30
Sep
2012

Thyroid Dysfunction in Chinese Patients with Chronic Hepatitis C Treated with Interferon Alpha: Incidence, Long-Term Outcomes and Predictive Factors

Zehui Yan,
Ke Fan,
Yi Fan,
Xiaohong Wang,
Qing Mao,
Guohong Deng
,et al.

Yan Z, Fan K, Fan Y, Wang X, Mao Q, et al. Thyroid Dysfunction in Chinese Patients with Chronic Hepatitis C Treated with Interferon Alpha: Incidence, Long-Term Outcomes and Predictive Factors. Hepat Mon. 2012;12(9):6390. doi: https://doi.org/10.5812/hepatmon.6390

30
Jun
2010

Interferon-Alpha Induced and Ribavirin Induced Thyroid Dysfunction in Patients with Chronic Hepatitis C

Amina Nadeem,
Muhammad Mazhar Hussain,
Muhammad Aslam,
Tassawar Hussain

Nadeem A, Hussain M, Aslam M, Hussain T. Interferon-Alpha Induced and Ribavirin Induced Thyroid Dysfunction in Patients with Chronic Hepatitis C. Hepat Mon. 2010;10(2):. doi:

10
Aug
2014

Occult Hepatitis C Virus Infection in Patients With Autoimmune Hepatitis

Mohammad Saeid Rezaee Zavareh,
Seyed Moayed Alavian,
Hamidreza Karimisari,
Mostafa Shafiei,
Seyed Yasser Saiedi Hosseini

Rezaee Zavareh MS, Alavian SM, Karimisari H, Shafiei M, Saiedi Hosseini SY. Occult Hepatitis C Virus Infection in Patients With Autoimmune Hepatitis. Hepat Mon. 2014;14(8):e16089. doi: https://doi.org/10.5812/hepatmon.16089

31
Jan
2006

The Frequency of Non Organ Specific Autoantibodies in Patients with Chronic Hepatitis C and Its Relation with Disease Severity and Response to Therapy

Naser Ebrahimi Daryani,
Hossein Bahrami,
Babak Haghpanah,
Mehdi Jalili,
Aliassad Hashtroudi,
Mohammad Bashashati
,et al.

Ebrahimi Daryani N, Bahrami H, Haghpanah B, Jalili M, Hashtroudi A, et al. The Frequency of Non Organ Specific Autoantibodies in Patients with Chronic Hepatitis C and Its Relation with Disease Severity and Response to Therapy. Arch Clin Infect Dis. 2006;1(1):. doi:

Download PDF178.72 KB
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles